INSTITUT PASTEUR DE TUNIS;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;SORBONNE UNIVERSITE
发明人:
申请号:
IL26729819
公开号:
IL267298D0
申请日:
2019.06.11
申请国别(地区):
IL
年份:
2019
代理人:
摘要:
The present invention relates to lebecetin, a functional variant or fragment thereof, for use as neovascularization inhibitor, in particular in the treatment of neovascular diseases such as ocular diseases, cancers or inflammatory disorders with a neovascular component.